Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study

RT can induce AR in patients with MM with PD under ICI, particularly with hypofractionated regimens and long ICI-to-RT intervals. Our findings can serve as a reference for designing prospective trials.

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-10-01
DOI
https://doi.org/10.1136/jitc-2025-012717
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study

Ping Jiang, Allison Lamrani, Raphael Bodensohn, Sally A. Elkhamisy et al.
1 citations
Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and Biomarkers
1.05
article

Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter study

Ping Jiang, Allison Lamrani, Raphael Bodensohn, Sally A. Elkhamisy, Cindy Franklin, Maike Trommer, Matthias Mäurer, Julian Philipp Layer, Alexander Rühle, Andrea Baehr, Sebastian Neppl, Simone Wegen, Maria Waltenberger, Danny Jazmati, Anna Hagemeier, Georg Wurschi, Felix Ehret, Davide Scafa, Annika Hardt, Charlotte Schmitter, Justus Kaufmann, Lukas Käsmann, Esther G.C. Troost
article en
1 citations

Abstract

RT can induce AR in patients with MM with PD under ICI, particularly with hypofractionated regimens and long ICI-to-RT intervals. Our findings can serve as a reference for designing prospective trials.

Journal for ImmunoTherapy of CancerVol. 13(10)
Universität Hamburg (DE), University of Freiburg (DE), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Johannes Gutenberg University Mainz (DE), University Hospital Bonn (DE), University Medical Center Freiburg (DE), Helmholtz-Zentrum Dresden-Rossendorf (DE), LMU Klinikum (DE), Humboldt-Universität zu Berlin (DE), Universitätsklinikum Erlangen (DE), Düsseldorf University Hospital (DE), Ospedale di Bolzano (IT), University Medical Center of the Johannes Gutenberg University Mainz (DE), Integrated Oncology (United States) (US), German Cancer Society (DE), Klinikum Lüdenscheid (DE), University Medical Center Hamburg-Eppendorf (DE), University Children's Hospital Tübingen (DE), Jena University Hospital (DE), OncoRay (DE), Comprehensive Cancer Center Erlangen (DE), University Hospital Cologne (DE), University Hospital Carl Gustav Carus (DE), Heinrich Heine University Düsseldorf (DE), Freie Universität Berlin (DE), Technische Universität Dresden (DE), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE), Leipzig University (DE)
Openalex Percentile: Top 17%
Cancer Immunotherapy and Biomarkers
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.